Jeffrey R. Binder has joined the Board of Directors of Minimus Spine, a company located in Austin, Texas. Binder is the current president and CEO of Immucor and the past CEO of Biomet (from 2007 until 2015).
According to the February 20, 2017 news release, “…Prior to his time at Biomet, Binder was president of Abbott Diagnostics from 2006 to 2007 and the CEO of Spinal Concepts from 2000 until it was acquired by Abbott Laboratories in 2003 and became Abbott Spine. Prior to Spinal Concepts, Mr. Binder was President of Depuy Orthopedics and he has spent most of his career in orthopedics and spine.”
David Hooper, Ph.D., Minimus Spine’s president and CEO said, “Jeff brings a wealth of intellect and experience to Minimus. He has successfully orchestrated several significant transactions in spine and orthopedics and is unquestionably a blue-chip addition as we strengthen the team around Triojection. Our management team and board worked together at Spinal Concepts. While that was a great result, the market need has expanded far beyond spinal hardware. We share the vision that Minimus is part of the future of spine and we expect continued success as we plan the initial commercial launch of Triojection in Europe this summer.”
Binder added: “I am very pleased to join the board of this exciting and innovative young company. Clinicians and patients are searching for solutions that address spinal disorders and reduce pain with less invasive approaches. I’m looking forward to working again with David and fellow director Wes Johnson, who were both so instrumental to our success at Spinal Concepts.”
Binder told OTW, “My first objective in this role is to help Minimus raise the capital it needs to achieve our highest priorities: (1) to demonstrate commercial traction in Europe, fulfilling the initial demand expressed by customers on David’s recent visit (2) to complete our European clinical studies and (3) to clarify our FDA pathway.”
